Matador were proud to have acquired the ability to both present and demonstrate Cara's relatively recently added CTMS (Clinical Trial Management System) capabilities in Japanese and with our SME adding Japanese clinical context to a large audience representing almost three quarters of the top twenty Japanese pharma.

As always, to enhance turnout for the event, Matador's specialised in-house event registration team made calls and emailed over four-hundred potential participants. Matador focused the phone recruitment on the top tier organisations and the fact that most of them were well represented speaks volumes to the hard work and good relationships we enjoy.

Clinical trial directors must be able to track multiple work streams running simultaneously, such as study and site initiation, patient recruitment, monitoring, and trial supply, and make operational decisions based on timely, accurate, and consistent data.

Matador's dedicated Generis team effectively demonstrated how the CARA Life Sciences platform can support efficient progress and management of clinical trials by centralizing all clinical trial data, including monitoring records, and the operation of various workflows.

John Bolger, CEO

Matador will be hosting more webinars in the near future. Please watch here for updates.